tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACLX Stock Latest News

3 ‘Strong Buy’ Stocks to Buy Today,12/23/2025, According to Top Analysts
Market News3 ‘Strong Buy’ Stocks to Buy Today,12/23/2025, According to Top Analysts
6d ago
ACLX
CGON
Midday Fly By: Ellison backstops Paramount bid for Warner Bros.
PremiumThe Fly
Midday Fly By: Ellison backstops Paramount bid for Warner Bros.
7d ago
LW
AMD
Arcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Arcellx initiated, Cummins upgraded: Wall Street’s top analyst calls
7d ago
CMI
SEE
3 ‘Strong Buy’ Stocks to Buy Today,12/22/2025, According to Top Analysts
PremiumMarket News
3 ‘Strong Buy’ Stocks to Buy Today,12/22/2025, According to Top Analysts
7d ago
ACLX
AMZN
Wells starts Arcellx with Overweight on multiple myeloma potential
PremiumThe Fly
Wells starts Arcellx with Overweight on multiple myeloma potential
7d ago
ACLX
Arcellx initiated with an Overweight at Wells Fargo
PremiumThe FlyArcellx initiated with an Overweight at Wells Fargo
7d ago
ACLX
Positive Outlook for Arcellx Inc: Buy Rating Backed by Strategic Positioning and Promising CAR T-cell Therapy
Premium
Ratings
Positive Outlook for Arcellx Inc: Buy Rating Backed by Strategic Positioning and Promising CAR T-cell Therapy
18d ago
ACLX
Arcellx Reports Promising Phase 2 Study Results
Premium
Company Announcements
Arcellx Reports Promising Phase 2 Study Results
20d ago
8K
ACLX
Promising Clinical Data and Favorable Safety Profile Drive Buy Rating for Arcellx Inc
PremiumRatings
Promising Clinical Data and Favorable Safety Profile Drive Buy Rating for Arcellx Inc
21d ago
ACLX
Arcellx Inc’s Promising Future: Buy Rating Backed by Strong Efficacy, Safety, and Strategic Partnerships
PremiumRatings
Arcellx Inc’s Promising Future: Buy Rating Backed by Strong Efficacy, Safety, and Strategic Partnerships
21d ago
ACLX
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
PremiumRatings
Arcellx Inc’s Anito-cel: Promising CAR-T Therapy with Superior Safety Profile and Market Readiness
21d ago
ACLX
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
PremiumRatings
Arcellx Inc’s Promising iMMagine-1 Study and Strategic Plans Justify Buy Rating and $112 Price Target
21d ago
ACLX
Optimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
PremiumRatingsOptimistic Buy Rating for Arcellx Inc: Promising Anito-cel Therapy and Strategic Advancements
21d ago
ACLX
Arcellx announces new data for its iMMagine-1 study in patients with RRMM
Premium
The Fly
Arcellx announces new data for its iMMagine-1 study in patients with RRMM
21d ago
ACLX
GILD
Gilead’s Kite announces new data for iMMagine-1 Study at ASH 2025
Premium
The Fly
Gilead’s Kite announces new data for iMMagine-1 Study at ASH 2025
22d ago
ACLX
GILD
Arcellx Inc’s Anito-cel: A Promising CAR-T Therapy with Strong Market Positioning and Growth Potential
PremiumRatings
Arcellx Inc’s Anito-cel: A Promising CAR-T Therapy with Strong Market Positioning and Growth Potential
1M ago
ACLX
Promising Outlook for Arcellx Inc’s Anito-cel Therapy in Multiple Myeloma Treatment
PremiumRatings
Promising Outlook for Arcellx Inc’s Anito-cel Therapy in Multiple Myeloma Treatment
1M ago
ACLX
Kelonia data too early to read to Gilead, Arcellx’s anito-cel, says BMO Capital
PremiumThe Fly
Kelonia data too early to read to Gilead, Arcellx’s anito-cel, says BMO Capital
1M ago
ACLX
GILD
Citi says Arcellx weakness on ‘highly preliminary’ Kelonia data an overreaction
PremiumThe Fly
Citi says Arcellx weakness on ‘highly preliminary’ Kelonia data an overreaction
1M ago
ACLX
Arcellx weakness on competitive worries ‘overdone,’ says Guggenheim
PremiumThe FlyArcellx weakness on competitive worries ‘overdone,’ says Guggenheim
1M ago
ACLX
Arcellx Inc’s Strategic Advantage in Gilead Partnership Drives Buy Rating and $130 Price Target
Premium
Ratings
Arcellx Inc’s Strategic Advantage in Gilead Partnership Drives Buy Rating and $130 Price Target
1M ago
ACLX
Arcellx initiated with a Peer Perform at Wolfe Research
Premium
The Fly
Arcellx initiated with a Peer Perform at Wolfe Research
1M ago
ACLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >